NCT01624428View on ClinicalTrials.gov

Varenicline on Reward Responses and Cognition in Adolescent Smokers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions
Tobacco Use Disorders
Interventions
DRUG

Varenicline

1 mg bid varenicline titrated over a 2 week period

DRUG

Placebo

1 mg bid placebo titrated over a 2 week period

Trial Locations (1)

06519

Substance Abuse Center, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT01624428 - Varenicline on Reward Responses and Cognition in Adolescent Smokers | Biotech Hunter | Biotech Hunter